X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.980
-0.020 (-0.50%)
At close: Jul 31, 2026, 4:00 PM EDT
3.970
-0.010 (-0.25%)
After-hours: Jul 31, 2026, 7:34 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $375.39 million as of July 31, 2026. Its market cap has increased by 3,563.80% in one year.
Market Cap
375.39M
Enterprise Value
218.93M
1-Year Change
3,563.80%
Ranking
Category
Stock Price
$3.98
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $375.39M, an increase of 268.85%. That is a compound annual growth rate of 19.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 375.39M | 7.33% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 405.14M |
| Evommune | 404.49M |
| vTv Therapeutics | 402.81M |
| Puma Biotechnology | 399.05M |
| Larimar Therapeutics | 395.61M |
| C4 Therapeutics | 387.54M |
| Atea Pharmaceuticals | 379.33M |
| Scribe Therapeutics | 372.19M |